Cepharanthine ( DrugBank: Cepharanthine )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 53 | Sjogren syndrome | 1 |
53. Sjogren syndrome
Clinical trials : 305 / Drugs : 325 - (DrugBank : 104) / Drug target genes : 58 - Drug target pathways : 188
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-jRCTs061180072 | 11/08/2011 | 19/03/2019 | Cepharanthine trial | Clinicopathological study on the efficacy of Cepharanthine for preventing salivary gland destruction in Sjogren's syndrome patients - Cepharanthine trial | SjS | Cepharanthine (6 mg / day) administration | Yamanoi Tomoko | NULL | Complete | >= 20age old | Not applicable | Both | 25 | Phase 2-3 | Japan |